机译:双氢青蒿素对Bcr / Abl +慢性粒细胞白血病K562细胞的生长抑制作用涉及AKT,ERK和NF-κB的调节
Department of Clinical Pharmacology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China;
Department of Clinical Pharmacology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China;
Department of Clinical Pharmacology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China;
Department of Clinical Pharmacology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China;
Department of Clinical Pharmacology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China;
Department of Clinical Pharmacology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China;
Dihydroartemisinin; Chronic myeloid leukemia; Bcr/Abl; AKT; ERK1/2; NF-κB;
机译:双氢青蒿素对Bcr / Abl +慢性粒细胞白血病K562细胞的生长抑制作用涉及AKT,ERK和NF-κB的调节。
机译:Allium Roseum L.提取物通过抑制BCR-ABL,PI3K / AKT和ERK1 / 2途径和VEGF分泌的消除,施加对慢性骨髓白血病K562细胞活力的有效抑制活性。
机译:ERK1 / 2的不依赖BCR-ABL的激活对K562慢性骨髓性白血病细胞中获得的伊马替尼耐药性的贡献。
机译:在K562细胞系和原发性慢性髓性白血病细胞中进行S1的临床前研究显示,它们与盐酸胞嘧啶阿拉伯糖苷具有协同作用
机译:针对性慢性粒细胞白血病治疗的新策略:破坏BCR-ABL1二聚化和继发性白血病特异性途径
机译:双氢青蒿素通过ROS毒性诱导自噬并抑制铁负载的人类白血病K562细胞的生长
机译:BCR的贡献 - 在K562慢性骨髓白血病细胞中获得IRK1 / 2的无关激活ERK1 / 2的耐受伊马替尼电阻